Abstract LB-B33: Nonclinical safety evaluation of two distinct second generation variants of anti-CTLA4 monoclonal antibody, ipilimumab, in monkeysKaren Price, Michael J. Graziano, Rima Srour et al.|Molecular Cancer Therapeutics|2018Cited by 11
Abstract 4551: Preclinical characterization of novel anti-CTLA-4 prodrug antibodies with an enhanced therapeutic indexJohn Engelhardt, Karen Price, Rahima Akter et al.|Cancer Research|2020Cited by 6